• Belimumab provokes rapid deterioration effect on B cells at early stages, but later stage B cells showed delayed to no response.• At baseline in SLE patients: ↑ of a novel B cell population: CD57+ B cells. Here, B3GAT1 is linked to systemic lupus erythematosus.